Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.59 USD | -7.02% | +16.06% | +25.20% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 10.3M |
---|---|---|---|---|---|
Net income 2024 * | -23M | Net income 2025 * | -27M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.89
x | P/E ratio 2025 * |
-1.18
x | Employees | 9 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.15% |
Latest transcript on Inhibikase Therapeutics, Inc.
1 day | -7.02% | ||
1 week | +16.06% | ||
Current month | -26.39% | ||
1 month | -26.39% | ||
3 months | -50.47% | ||
6 months | +91.01% | ||
Current year | +25.20% |
Managers | Title | Age | Since |
---|---|---|---|
Milton Werner
FOU | Founder | 61 | 08-08-31 |
C. Warren Olanow
CTO | Chief Tech/Sci/R&D Officer | - | 21-01-03 |
Surendra Singh
COO | Chief Operating Officer | - | 14-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Berman
BRD | Director/Board Member | 73 | 19-08-31 |
Paul Grint
BRD | Director/Board Member | 66 | 20-12-21 |
Milton Werner
FOU | Founder | 61 | 08-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 1.59 | -7.02% | 40,442 |
24-04-26 | 1.71 | -10.00% | 98,983 |
24-04-25 | 1.9 | +1.60% | 21,668 |
24-04-24 | 1.87 | +18.35% | 62,249 |
24-04-23 | 1.58 | +15.33% | 79,090 |
Delayed Quote Nasdaq, April 29, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.20% | 10.3M | |
+1.77% | 42.86B | |
+46.00% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- IKT Stock